Sort
130,381 grants matching “hiv”
Mental Retardation and Developmental Disabilities Research Centers 2006
$1,724,826Scott Loren Pomeroy · Boston Children'S Hospital · P30 · FY2009 · HD
ADULT AIDS CLINICAL TRIALS UNIT
$1,724,582New York University School Of Medicine · U01 · FY2005 · AI
NEUROAIDS--EFFECTS OF METHAMPHETAMINE
$1,724,571University Of California San Diego · P01 · FY2001 · DA
TIM family of genes: Role in T cell immunity and tolerance
$1,724,467Vijay K Kuchroo · Brigham And Women'S Hospital · P01 · FY2019 · AI
Natural Products Discovery and Characterization Through Network Collaborations
$1,724,356Lin Du · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
ADULT AIDS CLINICAL TRIALS GROUP
$1,724,255University Of Alabama At Birmingham · U01 · FY2000 · AI
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies
$1,724,205Pamela J Bjorkman · California Institute Of Technology · P01 · FY2024 · AI
CTR FOR COORD, ANALYSIS AND MANAGEMENT OF MACS RESEARCH
$1,724,138Johns Hopkins University · U01 · FY2001 · AI
California-Mexico-Puerto Rico Partnership (CAMPO) Center for Prevention of HPV-related Cancer in HIV+ Populations
$1,723,723Joel Palefsky · University Of California, San Francisco · U54 · FY2020 · CA
Targeting mechanisms of T cell homeostasis to purge the HIV reservoir
$1,723,647Rafick-Pierre Sekaly · University Of California, San Francisco · U19 · FY2014 · AI
STRENGTHENING HIV AIDS PROGRAM EFFICIENCIES IN DAR ES SALAAM (SHAPE DAR PROJECT F
$1,723,497Guerino Chalamilla · Management And Development For Health · U2G · FY2012 · GH
Medical Education for Services to All Ugandans (MESAU)
$1,723,333Nelson K Sewankambo · Makerere University College Of Health Sciences · R24 · FY2011 · TW
Programmatic: Expanding Innovative Multidisciplinary Medical Education in Zambia
$1,723,333Yakub F Mulla · University Of Zambia · R24 · FY2011 · TW
ENHANCING, TRAINING, RESEARCH CAPACITY AND EXPERTISE IN HIV CARE-ENTREE
$1,723,333Umesh G Lalloo · University Of Kwazulu-Natal · R24 · FY2011 · TW
Pathogenesis of viral meningitis
$1,723,327Dorian McGavern · National Institute Of Neurological Disorders And Stroke · ZIA · FY2009 · NS
Mechanisms Underlying Clearance of the Persistently Infected CNS
$1,723,327Dorian McGavern · National Institute Of Neurological Disorders And Stroke · ZIA · FY2009 · NS
HIV Neurobehavioral Research Center
$1,723,084Robert Kernachan Heaton · University Of California, San Diego · P30 · FY2016 · MH
Human Papillomavirus (HPV) Genomics Project
$1,722,953Lisa Mirabello · Division Of Cancer Epidemiology And Genetics · ZIA · FY2025 · CA
PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS
$1,722,804Seema Dixit · Rhode Island State Dept Of Health · U62 · FY2013 · PS
Assessment of Heterologous Prime-boost HIV Vaccine Regimen to Elicit Cross-reactive Neutralizing Antibodies Targeting HIV Fusion Peptide
$1,722,748Ronald Veazey · Tulane University Of Louisiana · N01 · FY2024 · AI
Mycobacterium Tuberculosis (MTB) Quality Assessment Program (TBQA)
$1,722,534Gene Garrard Olinger · Midwest Research Institute · N01 · FY2025 · AI
Trial for the Optimal Timing of HIV Therapy after Cryptococcal Meningitis
$1,722,067David R Boulware · University Of Minnesota · U01 · FY2011 · AI
Emory WIHS CRS - Longitudinal Cohort
$1,721,973Ighovwerha Ofotokun · Emory University · U01 · FY2016 · AI
High-Definition Characterization of the Persistence and Perturbation of the HIV Reservoir
$1,721,792Jonathan Li · Brigham And Women'S Hospital · P01 · FY2023 · AI
Novel Adjunctive Therapies for NeuroAIDS
$1,721,662Harris A Gelbard · University Of Rochester · P01 · FY2009 · MH